96% of Online Pharmacies Operating Illegally, Reveals Report

As per the report, these unregulated platforms often sell counterfeit medications that evade safety standards, posing severe risks to consumers. The issue has become even more pressing in 2024, as counterfeit drugs are increasingly sold to unsuspecting buyers who believe they are purchasing legitimate pharmaceuticals.

The convenience of purchasing medications online has become more widespread, especially during the COVID-19 pandemic, which saw an explosion in e-commerce. While legitimate online pharmacies are licensed and regulated, the majority of these online sellers are operating outside the law. These illicit websites frequently offer prescription drugs without requiring a valid prescription, making them highly attractive but extremely dangerous to consumers.

Statistics from the Alliance for Safe Online Pharmacies (ASOP) reveal that 20 new illicit pharmacy websites are created every day. Many of these websites appear legitimate, offering brand-name medications at discounted prices, but they lack proper oversight, which means consumers are unknowingly purchasing potentially dangerous and counterfeit drugs.

Counterfeit medications are often manufactured with substandard or harmful ingredients, and can have deadly consequences. Studies show that 38% of global counterfeit medicine seizures involve counterfeit U.S. brands, which are often targeted by criminals because of their widespread recognition and trust. Even when counterfeit drugs contain the right active ingredients, they may be mixed with harmful substances or produced in unsanitary conditions.

The risks associated with buying medications from illicit online pharmacies are growing. According to a 2023 survey, 24% of Americans who bought prescription drugs from these illegal sites reported exposure to substandard or counterfeit medications. This is a significant increase from previous years, highlighting the urgent need for stronger consumer awareness and enforcement.

U.S. authorities are taking action. In September 2024, the Department of Justice announced charges against 18 individuals involved in manufacturing and distributing counterfeit pills. The case represents just one of many ongoing efforts to shut down these illegal operations. However, the international nature of the problem makes enforcement challenging, as many illicit pharmacies are based outside the U.S., complicating the regulatory process.